Cargando…

The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011–2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group

PURPOSE: Our objective was to evaluate the utility of the national database (NDB) based on health insurance claims data for antimicrobial use (AMU) surveillance in medical institutions in Japan. METHODS: The population-weighted total AMU expressed as defined daily doses (DDDs) per 1000 inhabitants p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamasaki, Daisuke, Tanabe, Masaki, Muraki, Yuichi, Kato, Genta, Ohmagari, Norio, Yagi, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871632/ https://www.ncbi.nlm.nih.gov/pubmed/29273972 http://dx.doi.org/10.1007/s15010-017-1097-x

Ejemplares similares

Characteristics and limitations of national antimicrobial surveillance according to sales and claims data
por: Kusama, Yoshiki, et al.
Publicado: (2021)

Age-specific Distribution of Antimicrobial Use Surveillance using National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB Japan) 2011–2013
por: Yamasaki, Daisuke, et al.
Publicado: (2017)

The first national survey of antimicrobial use among dentists in Japan from 2015 to 2017 based on the national database of health insurance claims and specific health checkups of Japan
por: Ono, Akane, et al.
Publicado: (2020)

2017. Age-specific Distribution of Antimicrobial Days of Therapy (DOT) Using National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB Japan): Comparison with Defined Daily Doses per 1,000 Inhabitants Per Day (DID)
por: Yamasaki, Daisuke, et al.
Publicado: (2019)

Effects of the cefazolin shortage on the sales, cost, and appropriate use of other antimicrobials
por: Koizumi, Ryuji, et al.
Publicado: (2021)

Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections
por: Muraki, Yuichi, et al.
Publicado: (2020)

Evaluation of the Correspondence between the Concentration of Antimicrobials Entering Sewage Treatment Plant Influent and the Predicted Concentration of Antimicrobials Using Annual Sales, Shipping, and Prescriptions Data
por: Azuma, Takashi, et al.
Publicado: (2022)

2021. Comparison of Patterns of National Oral Antibiotic Use Between All Dentists and Medical Doctors in Japan in 2016 Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB)
por: Ishikane, Masahiro, et al.
Publicado: (2019)

Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance
por: Koizumi, Ryuji, et al.
Publicado: (2021)

Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings
por: Kusama, Yoshiki, et al.
Publicado: (2020)

773. First National Survey of Antibiotic Use Prescribed by All Dentists in Japan from 2015 to 2017 using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB)
por: Ishikane, Masahiro, et al.
Publicado: (2019)

Search for Indexes to Evaluate Trends in Antibiotic Use in the Sub-Prefectural Regions Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Mizuno, Kanako, et al.
Publicado: (2022)

Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study
por: Ono, Akane, et al.
Publicado: (2021)

Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
por: Goto, Ryota, et al.
Publicado: (2022)

Tuberculosis Test Usage and Medical Expenditures from Outpatient Insurance Claims Data, 2013
por: Owusu-Edusei, Kwame, et al.
Publicado: (2017)

Approaches for quantifying antimicrobial consumption per animal species based on national sales data: a Swiss example, 2006 to 2013
por: Carmo, Luís P, et al.
Publicado: (2017)

1785. Regional Variation of Antimicrobial Use in Japan From 2013 to 2016
por: Kusama, Yoshiki, et al.
Publicado: (2018)

Comparison of different biomass methodologies to adjust sales data on veterinary antimicrobials in the USA
por: Bulut, Ece, et al.
Publicado: (2021)

1806. The gap in the amount of monthly antimicrobial use according to the data source: Electronic Health Record Data vs. National Health Insurance Claim Data in Korea
por: Kim, Bongyoung, et al.
Publicado: (2022)

The Impact of Restricting Over-the-Counter Sales of Antimicrobial Drugs: Preliminary Analysis of National Data
por: Moura, Maria Luísa, et al.
Publicado: (2015)

Effects of population age structure on parenteral antimicrobial use estimations
por: Koizumi, Ryuji, et al.
Publicado: (2023)

Antibiotic Use during Pregnancy in South Korea Using 2011–2020 National Health Insurance Claims Data
por: Chae, Jungmi, et al.
Publicado: (2023)

Antimicrobials-induced esophageal ulcer
por: Ide, Satoshi, et al.
Publicado: (2021)

Cost and healthcare utilization of methicillin-resistant Staphylococcus aureus bacteremia estimated from linked antimicrobial resistance surveillance and hospital claims data in Japan
por: Shoji, Tomokazu, et al.
Publicado: (2022)

Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

Parasitic infections and medical expenses according to Health Insurance Review Assessment claims data in South Korea, 2011–2018
por: Kim, Ju Yeong, et al.
Publicado: (2019)

Patterns of care for glaucoma patients in Korea from 2002 to 2013 using the national health insurance service claims data
por: Choi, Seulggie, et al.
Publicado: (2018)

Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013–2014
por: Schmidt, Christian, et al.
Publicado: (2021)

Data Privacy Compliant Validation of Health Insurance Claims Data: the IDOMENEO Approach
por: Behrendt, Christian-Alexander, et al.
Publicado: (2020)

Case study data for joint modeling of insurance claims and lapsation
por: Guillen, Montserrat, et al.
Publicado: (2021)

Predicting health outcomes in dogs using insurance claims data
por: Debes, Christian, et al.
Publicado: (2023)

Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data
por: Ki, Moran, et al.
Publicado: (2017)

Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017
por: Kamata, Kazuhiro, et al.
Publicado: (2018)

Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013–2018
por: Ide, Satoshi, et al.
Publicado: (2023)

Incidence and Direct Medical Cost of Adjustment Disorder and in Korea Using National Health Insurance Service Claims Data From 2011 to 2017
por: Yang, Kyo-Jin, et al.
Publicado: (2021)

Record Linkage of secondary data in the NAKO: Overview of data sources with focus on health insurance claims data
por: Ahrens, W, et al.
Publicado: (2023)

Studies of Health Insurance Claims Data in Japan: A Scoping Review
por: Suto, Maiko, et al.
Publicado: (2023)

Diagnosis and management of hidradenitis suppurativa: Analysis of US insurance claims data
por: Xiong, Betty, et al.
Publicado: (2023)

Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
por: Mahlapuu, Margit, et al.
Publicado: (2016)

Intramammary antimicrobial sales in Ireland: a 2020 descriptive update
por: McAloon, Catherine I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ccs7gjvm8tg37ae1ja6cp7138a